News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

A.T.S. Pharmaceuticals, A Division of Auriga Laboratories, Inc. (ARGA.OB), Adds to Its Xyralid(TM) Franchise with the Introduction of Xyralid(TM) Cream


9/6/2007 10:56:45 AM

LOS ANGELES--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and xerostomia, announced today the launch of Xyralid™ Cream (lidocaine HCl 3%/hydrocortisone acetate 1%), a convenience kit that also contains Cleré™, a soap free cleanser. Xyralid™ Cream is the third product in the Xyralid™ franchise which also includes Xyralid™ RC (lidocaine HCl 3%/hydrocortisone acetate 1%) and Xyralid™ LP Lotion (lidocaine HCl 3%/hydrocortisone acetate 0.5%).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES